Target intelligence / Profile preview

Nucleolar and spindle-associated protein 1 (NUSAP1)

Target
NUSAP1
Molecular classification
Microtubule-associated protein, Cell cycle–associated protein, Other
01

Overview

Nucleolar and spindle-associated protein 1 (NUSAP1) is a microtubule-associated protein essential for mitotic progression, spindle assembly, chromosome segregation, and cell cycle regulation[1][3][4][5]. It binds directly to microtubules, promotes spindle formation, and participates in chromosome attachment during mitosis[4][5]. NUSAP1 is tightly regulated, cycling in expression and undergoing post-translational modifications such as SUMOylation to modulate its function[3]. High expression of NUSAP1 is documented in multiple cancers, correlating with poor prognosis and increased DNA damage repair via interaction with RAD51[1]. Knockdown or inhibition suppresses tumor cell proliferation and sensitizes cells to drugs like fludarabine and ibrutinib[1]. NUSAP1 is also a marker for cell proliferation, is involved in apoptosis and cell migration, and has been implicated in developmental disorders when mutated or dysregulated[5]. Its potential as a therapeutic target lies in its pivotal mitotic functions and its oncogenic activity in various malignancies.

Other names
ANKTBM-037PRO0310NuSAPFLJ13421LNPSAPLBM037PRO0310p1Q0310nucleolar protein ANKT
02

Mechanism of action

Sensitization of tumor cells to chemotherapeutics by NUSAP1 knockdown; Regulation of DNA damage repair pathway via RAD51 binding; Microtubule stabilization and spindle organization interference

03

Biological functions

Spindle microtubule organizationChromosome segregationCell cycle progressionCell proliferationApoptosis regulationDNA damage repairResponse to cellular stimulusCell migrationMitotic spindle assembly
04

Disease associations

Cancer (including chronic lymphocytic leukemia, liver, breast, prostate, gastric, bladder, cervical, pituitary tumors)Tumor progressionMicrocephaly, seizures, and developmental delayOther malignancies
05

Safety considerations

Potential toxicity via cell cycle arrest in normal proliferating cellsGenomic instability risk if disruptedOncogenic risk due to upregulation in cancersTargeting may cause side effects linked to mitosis inhibition
06

Interacting drugs

Fludarabine

1 more in the full profile.

07

Biomarkers

Overexpression associates with poor prognosis in several cancers (CLL, breast, cervical)Marker for cell proliferationPotential predictive marker for chemotherapy sensitivity

Beyond the preview

Go deeper on Nucleolar and spindle-associated protein 1 (NUSAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleolar and spindle-associated protein 1 (NUSAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call